ArticleCureus2025

Efficacy and Safety of Once-Weekly Trelagliptin As Compared to Twice-Daily Vildagliptin in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Phase 3, Non-inferiority Clinical Trial.

Bhupesh Dewan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.